Gregory R. Bluemling

机构：Emory University · ORCID：0000-0001-9138-7578

发表论文 23 篇 · 总被引 2972 次 · h-index 15

代表论文

• An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice (2020 · Science Translational Medicine · 被引 1168)
• SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801 (2021 · Nature · 被引 432)
• Small-Molecule Antiviral β- d - N 4 -Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance (2019 · Journal of Virology · 被引 355)
• Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia (2019 · Science Translational Medicine · 被引 339)
• 4′-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication (2022 · Science · 被引 137)
• The prophylactic and therapeutic activity of a broadly active ribonucleoside analog in a murine model of intranasal venezuelan equine encephalitis virus infection (2019 · Antiviral Research · 被引 113)